课题基金 / 基金详情

Basic and Clinical Studies on Natural Antioxidant Astaxanthin on the Inhibition of Diabetic Complication

Basic and Clinical Studies on Natural Antioxidant Astaxanthin on the Inhibition of Diabetic Complication
天然抗氧化剂虾青素抑制糖尿病并发症的基础与临床研究
批准号:
16300240
负责人:
NGUYEN Van Chuyen
金额:
$6.4万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

NGUYEN Van Chuyen的其他基金

相似基金

相关文献

中文摘要
翻译
本研究将类胡萝卜素虾青素与其他抗氧化剂如生育酚、生育三烯醇、抗坏血酸或黄原酚(松树多酚的混合物)联合应用于糖尿病大鼠,以证实其抗氧化应激和糖尿病并发症的有效性。在STZ糖尿病大鼠上进行了实验,证实了以下结果:在糖尿病大鼠中,虾青素与生育酚或生育三烯醇联合喂养,观察到强烈的氧化应激抑制作用。糖尿病大鼠尿8-OHdG生物标志物也低于对照组。而服用虾青素和大剂量抗坏血酸的糖尿病大鼠,其脂质过氧化水平高于对照组。由此可见,大剂量的抗坏血酸加速了体内的氧化作用。此外,与虾青素联合使用,降低了生育酚的消耗,t…增加母鸡血清和内脏中生育酚的浓度,并将水溶性黄原酚与虾青素合用以抑制糖尿病并发症。结果表明,与黄原酚合用后,小鼠肝、肾和血清中的过氧化脂质含量均低于对照组。白内障程度也低于对照组。尿8-OHdG生物标志物也低于对照组。由此可见,虾青素与黄原醇合用对糖尿病大鼠的脂质过氧化有明显的抑制作用。由此可见,虾青素与生育酚、生育酚或黄原酚合用对糖尿病并发症的抑制是有效的。糖尿病在发达国家和发展中国家都在增加。对于糖尿病并发症的抑制,希望本研究结果能为糖尿病并发症的预防方法提供参考。在人体上的临床试验将在来年在这家医院进行。较少
英文摘要
In this study, Astaxanthin, a kind of Carotenoid, was used in combination with other antioxidants such as Tocopherol, Tocotrienol, Ascorbic acid or Flavengenol (a mixture of polyphenols from pine) in diabetic rats, to confirm the effectiveness of these combinations against oxidative stress and diabetic complications.The experiments were carried out on STZ diabetic rats, then, the following results were confirmed : In the diabetic rats fed with Astaxanthin in combination with Tocopherol or Tocotrienol the strong inhibition of oxidative stress was observed. The 8-OHdG biomarker in urine of diabetic rats was also lower than that of the control. However, in the diabetic rats fed with Astaxanthin in combination with high dose of Ascorbic acid, the lipid peroxide was higher than that of the control. From this result, it can be concluded that high dose of Ascorbic acid accelerated the oxidation in vivo. Besides, by the combination with Astaxanthin, the comsumption of Tocopherol was reduced, t … More hen the concentration of Tocopherol in serum and internal organs were increased.Moreover, water soluble Flavengenol was used in the combination with Astaxanthin for the inhibition of diabetic complications. Then, the results showed that with the combination with Flavengenol, the lipid peroxide in liver, kidney and serum were lower than that of the control. The degree of cataract was also lower than that of the control. The 8-OHdG biomarker in urine was also lower than that of the control. From these results, Astaxanthin by the combination with Flavangenol, the inhibition of lipid peroxide in diabetic rats was significant.From these above results, Astaxanthin in the combination with Tocopherol, Tocotrienol or Flavengenol was effective for the inhibition of diabetic complications. Diabetes is increasing in developed and developing countries. For the inhibition of diabetic complications, it is hoped that the results in this study will be reference for the prevention method of diabetic complications. The clinical trials in human will be carried out in the coming year, in the hospital.. Less
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
糖尿病の予防・抑制におけるベトナム産Nu Voiの基礎および臨床に関する研究
  • 批准号:
    19300253
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $9.07万
  • 财政年份:
    2007
  • 负责人:
    NGUYEN Van Chuyen
  • 依托单位:
Structures determination of biological peptides generated by hydrolyzation of modified milk casein
  • 批准号:
    13680162
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.5万
  • 财政年份:
    2001
  • 负责人:
    NGUYEN Van Chuyen
  • 依托单位:
ビタミンEによる糖尿病合併症抑制機構に関する研究
  • 批准号:
    07660175
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 资助金额:
    $1.28万
  • 财政年份:
    1995
  • 负责人:
    NGUYEN Van Chuyen
  • 依托单位:
ペプチドと糖との反応生成物による生体内過酸化脂質生成の抑制に関する研究
  • 批准号:
    04808013
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 资助金额:
    $1.09万
  • 财政年份:
    1992
  • 负责人:
    NGUYEN Van Chuyen
  • 依托单位:
国内基金
海外基金
基于PI3K/Akt-Nrf2/ARE通路探讨Astaxanthin对脑出血后脑损伤的保护作用和机制
  • 批准号:
    81601155
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    17.0万元
  • 批准年份:
    2016
  • 负责人:
    胡鑫
  • 依托单位: